266 related articles for article (PubMed ID: 7126178)
1. Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies.
Ototani N; Kikuchi M; Yosizawa Z
Biochem J; 1982 Jul; 205(1):23-30. PubMed ID: 7126178
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-inhibitory activity of whale heparin oligosaccharides.
Ototani N; Kodama C; Kikuchi M; Yosizawa Z
J Biochem; 1984 Dec; 96(6):1695-703. PubMed ID: 6530392
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulant activity of heparin octasaccharide.
Ototani N; Yosizawa Z
J Biochem; 1981 Nov; 90(5):1553-6. PubMed ID: 7338523
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory activities for thrombin and factor Xa of whale heparin: comparative studies on two preparations from different species.
Ototani N; Yosizawa Z
Tohoku J Exp Med; 1986 Sep; 150(1):77-82. PubMed ID: 3775773
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
Nagasawa K; Uchiyama H
J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
[TBL] [Abstract][Full Text] [Related]
6. The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies.
Casu B; Oreste P; Torri G; Zoppetti G; Choay J; Lormeau JC; Petitou M; Sinäy P
Biochem J; 1981 Sep; 197(3):599-609. PubMed ID: 7325974
[TBL] [Abstract][Full Text] [Related]
7. Sulfated oligosaccharides isolated from the deamination products of heparins.
Kosakai M; Yosizawa Z
J Biochem; 1981 Jun; 89(6):1933-44. PubMed ID: 6270073
[TBL] [Abstract][Full Text] [Related]
8. Structures of five sulfated hexasaccharides prepared from porcine intestinal heparin using bacterial heparinase. Structural variants with apparent biosynthetic precursor-product relationships for the antithrombin III-binding site.
Tsuda H; Yamada S; Yamane Y; Yoshida K; Hopwood JJ; Sugahara K
J Biol Chem; 1996 May; 271(18):10495-502. PubMed ID: 8631846
[TBL] [Abstract][Full Text] [Related]
9. Sequence variation in heparin octasaccharides with high affinity for antithrombin III.
Atha DH; Stephens AW; Rimon A; Rosenberg RD
Biochemistry; 1984 Nov; 23(24):5801-12. PubMed ID: 6525337
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites.
Toida T; Hileman RE; Smith AE; Vlahova PI; Linhardt RJ
J Biol Chem; 1996 Dec; 271(50):32040-7. PubMed ID: 8943254
[TBL] [Abstract][Full Text] [Related]
11. Contribution of chemical 6-O-sulfation of the aminodeoxyhexose residues in whale heparin with high affinity for antithrombin III to its anticoagulant properties.
Uchiyama H; Metori A; Ogamo A; Nagasawa K
J Biochem; 1990 Mar; 107(3):377-80. PubMed ID: 2341372
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity.
Choay J; Petitou M; Lormeau JC; Sinaÿ P; Casu B; Gatti G
Biochem Biophys Res Commun; 1983 Oct; 116(2):492-9. PubMed ID: 6651824
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
[TBL] [Abstract][Full Text] [Related]
14. Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.
Cerskus AL; Birchall KJ; Ofosu FA; Hirsh J; Blajchman MA
Can J Biochem Cell Biol; 1984 Oct; 62(10):975-83. PubMed ID: 6509363
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.
Lane DA; Denton J; Flynn AM; Thunberg L; Lindahl U
Biochem J; 1984 Mar; 218(3):725-32. PubMed ID: 6721831
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant activity of artificial biomedical materials with co-immobilized antithrombin III and heparin.
Miura Y; Aoyagi S; Ikeda F; Miyamoto K
Biochimie; 1980; 62(8-9):595-601. PubMed ID: 7417594
[TBL] [Abstract][Full Text] [Related]
17. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
Scully MF; Kakkar VV
Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III.
Baruch D; Lindhout T; Wagenvoord R; Hemker HC
Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193
[TBL] [Abstract][Full Text] [Related]
19. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa.
Danielsson A; Raub E; Lindahl U; Björk I
J Biol Chem; 1986 Nov; 261(33):15467-73. PubMed ID: 3782075
[TBL] [Abstract][Full Text] [Related]
20. Conformational transitions induced in heparin octasaccharides by binding with antithrombin III.
Guerrini M; Guglieri S; Beccati D; Torri G; Viskov C; Mourier P
Biochem J; 2006 Oct; 399(2):191-8. PubMed ID: 16796563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]